FDA Clearance Tracker · P950005-S011
CELSIUS DIAGNOSTIC/ABLATION DEFLECTABLE TIP CATHETER
Last checked: Nov 20, 2026Latest source record: Jun 27, 2001 (this decision)Source: openFDAMethods & limitations
Decided
Jun 27, 2001
Approved
Time to decision
126 days
Received Feb 21, 2001. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class II
The decision
- FDA number
- P950005-S011
- Device name
- CELSIUS DIAGNOSTIC/ABLATION DEFLECTABLE TIP CATHETER
- Applicant
- Biosense Webster, Inc.
- Applicant location
- Irvine, CA
- Received
- Feb 21, 2001
- Decided
- Jun 27, 2001
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P950005
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.1220
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR CHANGES IN THE SCREWING MECHANISM OF THE REDEL CONNECTOR AND THE VENT HOLE PLACEMENT IN THE CELSIUS(TM) CATHETER.
Source documents
Other decisions for Biosense Webster, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Dual Energy THERMOCOOL SMARTTOUCH SF SystemPMA supplement
P030031-S141 · Decided Jul 1, 2026 · 279 days after receipt · Panel Track
Device type: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter (OAD) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.